Pharmacally
Hepatitis D
Approvals, trial readouts, research and drug safety alerts, interpreted by pharmacists and checked against the primary source.
Latest in Hepatitis D
Health TidingsMirum’s Brelovitug Makes Strong Case in Hepatitis DMirum Pharmaceuticals’ investigational antibody brelovitug achieved the primary endpoint in its second registrational Phase 3 study, AZURE-4, demonstrating combined virologic response and ALT normalization in patients with chronic…Fact-Checked
Health TidingsFDA Accepts Lonafarnib NDA for Chronic Hepatitis D, Advancing Potential First Oral TherapyEIT Pharma’s NDA for investigational oral lonafarnib has been accepted for FDA review in chronic hepatitis D.Fact-Checked
Explore more
Health TidingsIndustry, pipeline and company news.
RegulatoryApprovals, policy and agency decisions.
ResearchPeer-reviewed studies and scientific breakthroughs.
Drug FinderLook up any drug: uses, dosing and safety.
From the HistoryLandmark moments in pharmaceutical history.
LatestEvery new story, as soon as it is published.